Oligonucleotide-Based Therapeutics: Aptamers

Oligonucleotide-Based Therapeutics: Aptamers This talk delves into the fascinating world of aptamers. Aptamers are short single-stranded nucleic acid oligomers, either DNA or RNA, known for their ability to form intricate three-dimensional structures. The development of aptamers relies on SELEX (systematic evolution of ligands by exponential enrichment), a process that allows researchers to fine-tune their characteristics during selection. Dr. Laura Santana from Clarivate will be joining us to introduce the captivating realm of aptamers and focus on their practical applications in the biomedical field. She will also explore the latest advancements in the field, including aptamers currently undergoing clinical trials. Understand the fundamental properties of aptamers Explore the SELEX process and how it enables the customization of aptamers for specific applications Gain insights into the diverse applications of aptamers in the biomedical field Discover the latest examples of these molecules making strides in clinical trials Cell Science Biopharma Genomics Dr. Laura Santana Senior Biomolecular Scientist Clarivate Acro Sino Thermo BioRad Sartorius